pyrotinib Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Female only (2)
Any (1)

Phase 2 (3)

Interventional (3)

Fudan University (1)
Peking University (1)
Shanghai Jiao Tong University School of Medicine (1)

No (2)
Yes (1)

No (3)

Adult (18+) (3)

I am/have/had

I am/have/hadmeasurable disease

I am/have/hadbreast cancer

I am/have/hadher2+ breast cancer

I am/have/hadprogesterone

I am/have/hadplatelet count

I am/have/hadgene amplification

I am/have/hadejection fraction

I am/have/hadinvasive breast cancer

I am/have/hadprogesterone receptor

I am/have/hadbreast cancer stage

I am/have/hadher2 gene amplification

I am/have/hadestrogen receptor

I am/have/hadestrogen

I am/have/hadadjuvant therapy

I am/have/hadtriple-negative breast cancer

I am/have/hadimmunohistochemistry

I am/have/hadbisphosphonate therapy

I am/have/hadstage iv breast cancer

I am/have/hadadenocarcinoma

I am/have/hadbreast carcinoma

added new label for I am/have/had

I am looking for

I am looking forpyrotinib

I am looking fortrastuzumab

I am looking forprogesterone

I am looking forestrogen

I am looking forcapecitabine

I am looking forpertuzumab

I am looking foremtansine

I am looking forpaclitaxel

I am looking forbisphosphonate

I am looking foreverolimus

added new label for I am looking for

Advanced Filters

Found 3 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Recruiting

Pyrotinib Trastuzumab Pertuzumab and Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer

This study aims to evaluate the efficacy and safety of pyrotinib in combination with trastuzumab, pertuzumab and nab-paclitaxel as neoadjuvant therapy in early stage or locally advanced HER2-positive breast cancer.

her2 positive breast carcinoma

erbb2 gene amplification

gene amplification

estrogen receptor

estrogen

0 views
16 Feb, 2024
1 location

Phase 2
For Seniors
For adults
Recruiting in 100s
Interventional Study
For Females
Recruiting

Trastuzumab Combined With Pyrrolidine and Chemotherapy for Locally HER2 Positive Breast Cancer

This study is a one-arm, open, phase II clinical study, and the study subjects are locally advanced and inflammatoryPatients with sexual or early HER2-positive breast cancer entered the trial period after signing informed consentTo evaluate trastuzumab combined with pyrrolitinib and chemotherapy regimen (TCbH+Py) for HER2 positive breastPathologic complete response rate …

primary lesion

targeted therapy

invasive breast cancer

bisphosphonate therapy

trastuzumab

0 views
16 Feb, 2024
1 location

Phase 2
For Seniors
For adults
Recruiting in 100s
Interventional Study
For Females
Recruiting

An Umbrella Trial Based on Molecular Pathway for Patients With Metastatic TNBC.

This is a Phase II, open-label, randomized controlled umbrella trial evaluating the efficacy and safety of multiple targeted treatment in patients with metastaticTNBC.

solid tumour

stage iv breast cancer

everolimus

capecitabine

measurable disease

0 views
16 Feb, 2024
1 location